| abstract |
Provided is an antiviral agent having a phosphorodiamidate morpholino oligomer having an antisense sequence directed against a portion of the genome of a Zika virus (ZIKV) strain. The antiviral agent has many uses, such as in pharmaceutical compositions, methods of treating ZIKV-mediated diseases, methods of preventing ZIKV-mediated diseases, methods of reducing or preventing replication of ZIKV in host cells, controlling ZIKV in In methods of diffusion in donated tissue, processed tissue samples, and in the preparation of medicaments for the treatment or prevention of ZIKV-mediated diseases. |